Literature DB >> 11498463

Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts.

J W Yarnell1, C C Patterson, P M Sweetnam, H F Thomas, D Bainton, P C Elwood, C H Bolton, N E Miller.   

Abstract

Several studies have suggested that men with raised plasma triglycerides (TGs) in combination with adverse levels of other lipids may be at special risk of subsequent ischemic heart disease (IHD). We examined the independent and combined effects of plasma lipids at 10 years of follow-up. We measured fasting TGs, total cholesterol (TC), and high density lipoprotein cholesterol (HDLC) in 4362 men (aged 45 to 63 years) from 2 study populations and reexamined them at intervals during a 10-year follow-up. Major IHD events (death from IHD, clinical myocardial infarction, or ECG-defined myocardial infarction) were recorded. Five hundred thirty-three major IHD events occurred. All 3 lipids were strongly and independently predictive of IHD after 10 years of follow-up. Subjects were then divided into 27 groups (ie, 3(3)) by the tertiles of TGs, TC, and HDLC. The number of events observed in each group was compared with that predicted by a logistic regression model, which included terms for the 3 lipids (without interactions) and potential confounding variables. The incidence of IHD was 22.6% in the group with the lipid risk factor combination with the highest expected risk (high TGs, high TC, and low HDLC) and 4.7% in the group with the lowest expected risk (P<0.01). A comparison of the predicted number of events in the 27 groups with the number of events observed showed that a logistic regression provided an adequate fit without the need to incorporate interactions between lipids in the model. Conclusions are as follows: (1) Serum TGs, TC, and HDLC are independently predictive of IHD at 10 years of follow-up. (2) Combinations of adverse levels of the 3 major lipid risk factors have no greater impact on IHD than that expected from their individual contributions in a logistic regression model. There was no evidence that men with low HDL/raised TGs were at significantly greater risk than that predicted from the independent effects of the 2 lipids considered individually.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498463     DOI: 10.1161/hq0801.093505

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 2.  Treatment of hypertriglyceridemia.

Authors:  Warren H Capell; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 3.  Hypertriglyceridemia-why, when and how should it be treated?

Authors:  I Gouni-Berthold; W Krone
Journal:  Z Kardiol       Date:  2005-11

Review 4.  Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia.

Authors:  Peter Alagona
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

5.  Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people.

Authors:  Anna Murray; Christie Cluett; Stefania Bandinelli; Anna Maria Corsi; Luigi Ferrucci; Jack Guralnik; Andrew Singleton; Timothy Frayling; David Melzer
Journal:  Eur Heart J       Date:  2009-05-12       Impact factor: 29.983

6.  Effects of R219K polymorphism of ATP-binding cassette transporter 1 gene on serum lipids ratios induced by a high-carbohydrate and low-fat diet in healthy youth.

Authors:  Hui Liu; Jia Lin; Xing Zhu; Yuan Li; Mei Fan; Rong Zhang; Ding Fang
Journal:  Biol Res       Date:  2014-03-26       Impact factor: 5.612

7.  Dietary Patterns in Relation to Cardiovascular Disease Incidence and Risk Markers in a Middle-Aged British Male Population: Data from the Caerphilly Prospective Study.

Authors:  Elly Mertens; Oonagh Markey; Johanna M Geleijnse; David Ian Givens; Julie A Lovegrove
Journal:  Nutrients       Date:  2017-01-18       Impact factor: 5.717

8.  Impact of multiple cardiovascular risk factors on carotid intima-media thickness and elasticity.

Authors:  Lili Niu; Yanling Zhang; Ming Qian; Long Meng; Yang Xiao; Yuanyuan Wang; Xin Liu; Rongqin Zheng; Hairong Zheng
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

Review 9.  The independent relationship between triglycerides and coronary heart disease.

Authors:  Alan Morrison; John E Hokanson
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

10.  A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.

Authors:  Nicholas J Timpson; Klaudia Walter; Josine L Min; Ioanna Tachmazidou; Giovanni Malerba; So-Youn Shin; Lu Chen; Marta Futema; Lorraine Southam; Valentina Iotchkova; Massimiliano Cocca; Jie Huang; Yasin Memari; Shane McCarthy; Petr Danecek; Dawn Muddyman; Massimo Mangino; Cristina Menni; John R B Perry; Susan M Ring; Amadou Gaye; George Dedoussis; Aliki-Eleni Farmaki; Paul Burton; Philippa J Talmud; Giovanni Gambaro; Tim D Spector; George Davey Smith; Richard Durbin; J Brent Richards; Steve E Humphries; Eleftheria Zeggini; Nicole Soranzo
Journal:  Nat Commun       Date:  2014-09-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.